Hepatocellular carcinoma: The need for progress

被引:355
作者
Thomas, MB
Zhu, AX
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Massachusetts Gen Hosp, Boston, MA 02115 USA
关键词
D O I
10.1200/JCO.2005.03.196
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2892 / 2899
页数:8
相关论文
共 129 条
[51]  
Kiss A, 1997, CLIN CANCER RES, V3, P1059
[52]   Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study [J].
Kouroumalis, E ;
Skordilis, P ;
Thermos, K ;
Vasilaki, A ;
Moschandrea, J ;
Manousos, ON .
GUT, 1998, 42 (03) :442-447
[53]  
KUO MT, 1992, CELL GROWTH DIFFER, V3, P531
[54]   Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma - A randomized controlled trial [J].
Lai, ECS ;
Lo, CM ;
Fan, ST ;
Liu, CL ;
Wong, J .
ARCHIVES OF SURGERY, 1998, 133 (02) :183-188
[55]   Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J].
Lau, WY ;
Leung, TWT ;
Ho, SKW ;
Chan, M ;
Machin, D ;
Lau, J ;
Chan, ATC ;
Yeo, W ;
Mok, TSK ;
Yu, SCH ;
Leung, NWY ;
Johnson, PJ .
LANCET, 1999, 353 (9155) :797-801
[56]   Differential expression of protein kinase C isoforms in diethylnitrosamine-initiated rat liver [J].
Lee, YS ;
Hong, SI ;
Lee, MJ ;
Kim, MR ;
Jang, JJ .
CANCER LETTERS, 1998, 126 (01) :17-22
[57]  
Li XM, 1998, J EXP CLIN CANC RES, V17, P13
[58]  
Li Y., 1999, Annals Academy of Medicine Singapore, V28, P67
[59]  
Liew CT, 1999, INT J CANCER, V81, P319, DOI 10.1002/(SICI)1097-0215(19990505)81:3<319::AID-IJC1>3.0.CO
[60]  
2-K